Section |
Status |
BlueTeq |
Name |
08.01.05 |
Formulary
|
 |
Abemaciclib tabs |
08.03.04.02 |
Formulary
|
 |
Abiraterone tabs |
11.99.99.99 |
Formulary
|
 |
Adalimumab injection uveitis |
13.05.03 |
Formulary
|
 |
Adalimumab injection Hidradenitis suppurativa |
08.01.05 |
Formulary
|
 |
Alectinib caps |
08.02.03 |
Formulary
|
 |
Alemtuzumab injection multiple sclerosis |
10.01.03 |
Formulary
|
 |
Anakinra injection Adult-Onset Still's Disease |
08.01.05 |
Formulary
|
 |
Arsenic trioxide injection |
08.01.05 |
Formulary
|
 |
Atezolizumab injection lung cancer indications |
08.01.05 |
Formulary
|
 |
Atezolizumab injection breast cancer indications |
08.01.05 |
Formulary
|
 |
Atezolizumab injection urothelial cancer indications |
08.01.05 |
Formulary
|
 |
Atezolizumab injection hepatocellular cancer indications |
08.01.05 |
Formulary
|
 |
Avelumab injection renal cell carcinoma |
08.01.05 |
Formulary
|
 |
Avelumab injection |
08.01.05 |
Formulary
|
 |
Axicabtagene ciloleucel cells dispersion for infusion |
08.01.05 |
Formulary
|
 |
Axitinib tabs |
05.01.09 |
Formulary
|
 |
Bedaquiline tabs Sirturo® |
10.01.03 |
Restricted Use
|
 |
Belimumab injection |
08.01.01 |
Formulary
|
 |
Bendamustine injection |
08.01.01 |
Formulary
|
 |
Bendamustine injection B-cell lymphoma |
03.04.02 |
Formulary
|
 |
Benralizumab injection |
08.01.05 |
Formulary
|
 |
Bevacizumab injection licensed use |
08.01.05 |
Formulary
|
 |
Binimetinib tabs |
08.02.03 |
Formulary
|
 |
Blinatumomab injection |
08.01.05 |
Formulary
|
 |
Bortezomib injection |
02.05.01 |
Restricted Use
|
 |
Bosentan tabs digital ulcer disease - off-label |
08.01.05 |
Formulary
|
 |
Bosutinib tabs |
08.01.05 |
Formulary
|
 |
Brentuximab injection |
08.01.05 |
Formulary
|
 |
Brigatinib tabs |
03.04.03 |
Formulary
|
 |
C1 esterase inhibitor injection |
08.01.05 |
Formulary
|
 |
Cabazitaxel injection |
08.01.05 |
Formulary
|
 |
Cabozantinib caps Cometriq - thyroid cancer |
08.01.05 |
Formulary
|
 |
Cabozantinib tablets Cabometyx - renal carcinoma |
04.06 |
Formulary
|
 |
Cannabidiol solution Epidyolex |
08.01.05 |
Formulary
|
 |
Carfilzomib injection |
08.01.05 |
Formulary
|
 |
Cemiplimab injection |
08.01.05 |
Formulary
|
 |
Ceritinib caps |
08.01.05 |
Formulary
|
 |
Cetuximab injection colorectal cancer |
08.01.05 |
Formulary
|
 |
Cetuximab injection head and neck cancer |
01.09.01 |
Formulary
|
 |
Chenodeoxycholic acid capsules |
01.09.01 |
Formulary
|
 |
Cholic acid capsules |
08.02.04 |
Formulary
|
 |
Cladribine tabs multiple sclerosis |
04.09.01 |
Formulary
|
 |
Co-careldopa intestinal gel Duodopa® |
08.01.05 |
Formulary
|
 |
Crizotinib caps |
08.01.03 |
Formulary
|
 |
Cytarabine and daunorubicin (liposomal) injection Vyxeos® |
08.01.05 |
Formulary
|
 |
Dabrafenib caps |
08.01.05 |
Formulary
|
 |
Dacomitinib caps |
08.02.04 |
Formulary
|
 |
Daratumumab injection |
08.01.05 |
Formulary
|
 |
Dasatinib tabs |
02.08.01 |
Formulary
|
 |
Defibrotide infusion |
05.01.09 |
Formulary
|
 |
Delamanid tabs Deltyba® |
08.02.04 |
Formulary
|
 |
Dimethyl fumarate caps Tecfidera - multiple sclerosis |
08.01.02 |
Formulary
|
 |
Doxorubicin hydrochloride pegylated liposomal injection |
08.01.05 |
Formulary
|
 |
Durvalumab injection |
09.01.03 |
Formulary
|
 |
Eculizumab injection prevention and management of delayed haemolytic transfusion reactions |
09.01.03 |
Formulary
|
 |
Eculizumab injection Atypical Haemolytic Uraemic Syndrome [aHUS] |
09.01.03 |
Restricted Use
|
 |
Eculizumab injection C3 glomerulopathy post-kidney transplant |
09.01.03 |
Formulary
|
 |
Emicizumab injection |
08.01.05 |
Formulary
|
 |
Encorafenib caps colorectal |
08.01.05 |
Formulary
|
 |
Encorafenib caps melanoma |
08.01.05 |
Formulary
|
 |
Entrectinib caps |
08.01.05 |
Formulary
|
 |
Entrectinib caps non-small cell lung cancer |
08.03.04.02 |
Formulary
|
 |
Enzalutamide tabs |
05.03.03.02 |
Formulary
|
 |
Epclusa® tabs sofosbuvir and velpatasvir |
08.01.05 |
Formulary
|
 |
Eribulin injection |
09.05.01.02 |
Formulary
|
 |
Etelcalcetide injection |
08.01.05 |
Formulary
|
 |
Everolimus tabs breast cancer |
08.01.05 |
Formulary
|
 |
Everolimus tabs neuroendocrine tumours |
08.01.05 |
Formulary
|
 |
Everolimus tabs seizures associated with tuberous sclerosis complex |
08.01.05 |
Formulary
|
 |
Everolimus tabs renal cancer |
08.02.04 |
Formulary
|
 |
Fingolimod caps |
08.03.04.01 |
Formulary
|
 |
Fulvestrant injection |
08.02.03 |
Formulary
|
 |
Gemtuzumab ozogamicin infusion |
08.01.05 |
Formulary
|
 |
Gilteritinib tabs |
08.02.04 |
Formulary
|
 |
Glatiramer acetate injection |
05.03.03.02 |
Formulary
|
 |
Harvoni® tabs sofosbuvir and ledipasvir |
08.01.05 |
Formulary
|
 |
Ibrutinib caps |
08.01.05 |
Formulary
|
 |
Inotuzumab ozogamicin injection |
08.02.04 |
Formulary
|
 |
Interferon beta-1a injection multiple sclerosis |
08.02.04 |
Formulary
|
 |
Interferon beta-1b injection multiple sclerosis |
08.01.05 |
Formulary
|
 |
Ipilimumab injection |
08.01.05 |
Formulary
|
 |
Isatuximab injection |
05.02.01 |
Formulary
|
 |
Isavuconazole tabs, injection |
08.02.04 |
Formulary
|
 |
Ixazomib caps |
03.04.03 |
Formulary
|
 |
Lanadelumab injection |
08.01.05 |
Formulary
|
 |
Larotrectinib oral solution |
08.02.04 |
Formulary
|
 |
Lenalidomide caps licensed use |
08.01.05 |
Formulary
|
 |
Lenvatinib caps renal cancer - Kisplyx® |
08.01.05 |
Formulary
|
 |
Lenvatinib caps thyroid cancer - Lenvima® |
08.01.05 |
Formulary
|
 |
Lenvatinib caps hepatocellular carcinoma - Lenvima® |
05.03.02.02 |
Formulary
|
 |
Letermovir tabs, injection |
08.01.05 |
Formulary
|
 |
Lorlatinib tabs Non-small-cell lung cancer |
08.01.05 |
Formulary
|
 |
Lutetium (177Lu) oxodotreotide injection |
03.07 |
Formulary
|
 |
Mannitol inhalation powder Bronchitol® |
05.03.03.02 |
Formulary
|
 |
Maviret® tabs glecaprevir and pibrentasvir |
03.04.02 |
Formulary
|
 |
Mepolizumab injection |
10.02.02 |
Formulary
|
 |
Mexiletine caps congenital myotonia |
08.01.05 |
Formulary
|
 |
Midostaurin caps |
08.02.04 |
Restricted Use
|
 |
Natalizumab injection |
08.01.05 |
Formulary
|
 |
Neratinib tabs |
08.01.05 |
Formulary
|
 |
Nilotinib caps |
03.11 |
Formulary
|
 |
Nintedanib caps Ofev® - idiopathic pulmonary fibrosis |
08.01.05 |
Formulary
|
 |
Niraparib caps |
08.01.05 |
Formulary
|
 |
Nivolumab injection head and neck, renal and skin cancer |
08.01.05 |
Formulary
|
 |
Nivolumab injection urothelial cancer |
08.01.05 |
Formulary
|
 |
Nivolumab injection haematological and lung cancer |
01.09.01 |
Formulary
|
 |
Obeticholic acid tabs |
08.02.03 |
Formulary
|
 |
Obinutuzumab injection |
08.02.04 |
Formulary
|
 |
Ocrelizumab injection |
08.01.05 |
Formulary
|
 |
Olaparib tabs |
03.04.02 |
Restricted Use
|
 |
Omalizumab injection asthma |
08.01.05 |
Formulary
|
 |
Osimertinib tabs |
08.01.05 |
Formulary
|
 |
Paclitaxel albumin injection Abraxane |
08.01.05 |
Formulary
|
 |
Palbociclib tabs |
08.01.05 |
Formulary
|
 |
Panitumumab injection |
08.03.04.03 |
Formulary
|
 |
Pasireotide injection |
08.02.04 |
Formulary
|
 |
Peginterferon beta-1a injection |
06.05.01 |
Formulary
|
 |
Pegvisomant injection |
08.01.05 |
Formulary
|
 |
Pembrolizumab injection skin cancer and head and neck cancer indications |
08.01.05 |
Formulary
|
 |
Pembrolizumab injection lymphoma and lung cancer indications |
08.01.05 |
Formulary
|
 |
Pembrolizumab injection urothelial cancer indications |
08.01.03 |
Formulary
|
 |
Pemetrexed injection |
08.01.05 |
Formulary
|
 |
Pertuzumab injection |
03.11 |
Formulary
|
 |
Pirfenidone caps |
09.01.07 |
Restricted Use
|
 |
Plerixafor injection |
08.01.05 |
Formulary
|
 |
Polatuzumab vedotin injection |
08.02.04 |
Formulary
|
 |
Pomalidomide caps |
08.01.05 |
Formulary
|
 |
Ponatinib tabs |
03.04.03 |
Formulary
|
 |
Recombinant C1 esterase inhibitor injection Ruconest, Conestat Alpha |
08.01.05 |
Formulary
|
 |
Regorafenib tabs gastrointestinal stromal tumours |
08.01.05 |
Formulary
|
 |
Regorafenib tabs hepatocellular carcinoma |
03.04.02 |
Formulary
|
 |
Reslizumab injection |
08.01.05 |
Formulary
|
 |
Ribociclib tabs |
10.01.03 |
Formulary
|
 |
Rituximab injection ANCA vasculitis |
10.01.03 |
Restricted Use
|
 |
Rituximab injection rheumatology - off-label indications |
10.02.01 |
Formulary
|
 |
Rituximab injection myaesthenia gravis - off-label |
13.05.03 |
Formulary
|
 |
Rituximab injection dermatology indications |
08.02.03 |
Formulary
|
 |
Rituxmab injection anti-NMDAR autoimmune encephalitis - off-label |
08.01.05 |
Formulary
|
 |
Rucaparib tabs |
10.01.03 |
Formulary
|
 |
Sarilumab pre-filled syringe COVID-19 pneumonia, given as an intravenous infusion - off-label |
08.01.05 |
Formulary
|
 |
Sorafenib tablets Hepatocellular carcinoma |
08.01.05 |
Formulary
|
 |
Sorafenib tablets thyroid cancer |
08.01.05 |
Formulary
|
 |
Sunitinib caps renal cell carcinoma |
08.01.05 |
Formulary
|
 |
Sunitinib caps gastrointestinal stromal tumours and neuroendocrine tumours |
08.01.05 |
Formulary
|
 |
Talimogene laherparepvec injection |
08.02.04 |
Formulary
|
 |
Teriflunomide tablets |
08.01.05 |
Formulary
|
 |
Tisagenlecleucel cells dispersion for infusion |
08.01.05 |
Formulary
|
 |
Tivozanib caps |
10.01.03 |
Formulary
|
 |
Tocilizumab COVID-19 pneumonia - off-label |
10.01.03 |
Formulary
|
 |
Tocilizumab cytokine relsease syndrome following CAR T-cell therapy |
10.01.03 |
Formulary
|
 |
Tocilizumab injection Adult-Onset Still's Disease |
10.01.03 |
Formulary
|
 |
Tocilizumab subcutaneous injection giant cell arteritis |
08.01.05 |
Formulary
|
 |
Trametinib tabs |
08.01.05 |
Formulary
|
 |
Trastuzumab emtansine injection |
08.01.01 |
Formulary
|
 |
Treosulfan injection |
09.08.01 |
Formulary
|
 |
Trientine dihydrochloride tabs |
08.01.03 |
Formulary
|
 |
Trifluridine–tipiracil tablets |
08.01.05 |
Formulary
|
 |
Venetoclax tabs |
05.03.03.02 |
Formulary
|
 |
Vosevi® tabs sofosbuvir, velpatasvir and voxilaprevir |
05.03.03.02 |
Formulary
|
 |
Zepatier® tabs elbasvir and grazoprevir |